MINNEAPOLIS – – November 03, 2026 -- Bio-Techne Corporation (NASDAQ: TECH) will pay a quarterly dividend of $0.08 per share only if its pending transaction with Merck KGaA, Darmstadt, Germany has not closed by the close of business on November 13, 2026.

Dividend payable November 23 to holders of record on November 13

The Board of Directors declared the payout for the quarter ended September 30, 2026. Payment is due November 23, 2026, to all common shareholders of record at the close of business on November 13, 2026. The record date doubles as the deadline for the deal condition. If the Merck KGaA transaction closes on or before that date, the dividend will not be paid.

Board will review future dividends quarterly

The board said it will consider future cash dividends on a quarterly basis, as applicable. The company gave no commitment on payouts beyond the current declaration.

Closing depends on shareholder and regulatory approvals

Bio-Techne named the timing of the transaction's completion as a key risk, including whether it closes before the record date. Other risks include receipt of required shareholder and regulatory approvals and the effect of the pending deal on the company's business, operations and stock price. The company points investors to the risk factors in its Form 10-K for the fiscal year ended June 30, 2026.

Bio-Techne reported net sales of more than $1.2 billion in fiscal 2026 and has approximately 3,000 employees worldwide.